Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PNFP | IBN |
|---|---|---|
| Price | $93.91 | $27.39 |
| Change today | ▲ 0.32% | ▼ 0.60% |
| Market cap | $14.19B | $98.29B |
| Return, 3 months | -6.4% | -4.7% |
| Return, year to date | – | -7.3% |
| Return, 1 year | – | -9.6% |
| P/E (TTM) | 12.9 | 17.6 |
| P/B | 1.0 | 2.6 |
| P/E percentile vs own 5y | 58th | 17th |
| Dividend yield | 1.58% | 0.85% |
| Revenue growth (YoY, latest qtr) | +146.1% | +7.7% |
| Net profit growth (YoY) | +106.3% | +12.6% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 24.2% | 24.8% |
| Return on equity | 7.7% | 15.8% |
| Analyst target vs. price | +28.9% | – |
| Analyst buy share | 81% | 100% |
| RSI (14) | 34 | 34 |
| 30-day volatility | 21.4% | 19.7% |
| Max drawdown, 1 year | -19.7% | -23.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
